Inflammatory Mechanisms in Depression and Cardiovascular Disease

A burgeoning body of research has elucidated how dysregulated immune responses contribute to both major depressive disorder and cardiovascular pathology. Systemic elevations of proinflammatory cytokines, such as interleukin-6 and tumour necrosis factor-α, promote endothelial dysfunction and accelerate atherogenesis, while disrupting neurotransmitter metabolism and neuroplasticity. Concurrently, altered platelet activation and adhesion-molecule expression exacerbate thromboinflammatory processes, linking mood disturbance to heightened vascular risk. In the central nervous system, microglial activation and breakdown of the blood-brain barrier permit peripheral immune mediators to perturb neuronal circuits governing mood and cognition. Autonomic imbalance further amplifies inflammatory cascades, creating a bidirectional interface between emotional and cardiovascular health. Understanding these convergent pathways is critical for devising targeted interventions that address both depression and vascular comorbidity.

Research from Nature Portfolio

Recent investigations have revealed that individuals with pre-existing mental disorders exhibit a distinct pattern of platelet activation following viral infection. One study of COVID-19 survivors demonstrated that platelets from patients with a psychiatric history showed preferential and sustained activation via non-classical pathways, implicating thromboinflammation in their heightened risk of adverse cardiovascular outcomes. This work highlights how psychiatric vulnerability may prime the haemostatic system towards a pro-thrombotic state, underscoring the need to monitor and modulate platelet function in at-risk populations.

Inflammatory Mechanisms in Depression and Cardiovascular Disease publication trend

The graph below shows the total number of articles in inflammatory mechanisms in depression and cardiovascular disease across all publications each year (not limited to Nature Index journals).

Technical terms

Proinflammatory cytokine: A signalling protein (e.g. interleukin-6, TNF-α) that promotes inflammation and can influence both vascular cells and brain function.

Endothelial dysfunction: Impaired performance of the blood-vessel lining, characterised by reduced nitric oxide availability, prothrombotic tendency and increased permeability.

Adhesion molecules: Surface proteins (e.g. ICAM-1, VCAM-1) that mediate leukocyte and platelet attachment to the endothelium, facilitating inflammatory cell recruitment.

Platelet activation: The process by which platelets change shape, secrete mediators and aggregate, contributing to clot formation and inflammatory signalling.

Thromboinflammation: The interplay between coagulation and immune responses, wherein clotting processes amplify inflammatory pathways and vice versa.

References

1. Preferential and sustained platelet activation in COVID-19 survivors with mental disorders. Scientific Reports (2024).
2. Differentiating Stages of Bipolar and Unipolar Depression—The Possible Role of sICAM-1 and sVCAM-1. Cells (2024).
3. Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model. Translational Psychiatry (2016).
4. Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study. Неврология, нейропсихиатрия, психосоматика (2022).